SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddy's Laboratories’ arm recalling Javygtor Powder for Oral Solution in US

21 May 2024 Evaluate

Dr. Reddy's Laboratories’ wholly-owned step-down subsidiary -- Dr. Reddy’s Laboratories, Inc. is recalling Javygtor (sapropterin dihydrochloride) Powder for Oral Solution (100mg) due to it being a ‘Sub-potent Drug’. The company is also recalling another lot of sapropterin dihydrochloride for the same reason.  The drug maker initiated the Class I recall in the US on April 8 this year. As per the US health regulator USFDA, a Class I recall pertains to defective products that can cause serious health problems.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Dr. Reddys Lab Share Price

1287.95 -35.00 (-2.65%)
04-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.10
Dr. Reddys Lab 1287.95
Cipla 1334.85
Zydus Lifesciences 901.65
Lupin 2350.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×